J Grund1, H Husbyn. Show Affiliations » 1. Centre for Health Economics, Norwegian School of Management, Oslo.
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug Therapy/economicsEconomics, PharmaceuticalHealth Care CostsHealth Policy/economicsNorwayTime Factors
Year: 1995 PMID: 10155333 DOI: 10.2165/00019053-199507060-00002
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981